NR
National Research Corporation
NRC · NASDAQ
$20.56 -1.49% (-$0.31)
1M -6.20%
Market Cap $463.4M
P/E Ratio 79.11x
Div. Yield 2.92%
ROE 48.46%
Bulios Fair Price
$19.74
4.0% downside
Current Price
$20.56
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NRC is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
26 /100
Expensive P/B 70.75x
P/S 3.31x
P/E 79.11x
Growth
1 /100
Declining Book val. growth 42.09%
FCF growth 15.86%
EPS growth 25.74%
Profitability
66 /100
Moderate FCF margin 15.46%
Op. margin 10.53%
Gross margin 66.79%
Quality
69 /100
Excellent Asset turnover 1.03x
ROA 4.30%
ROIC 8.75%
Debt
20 /100
High Net debt/EBITDA 3.70x
Int. coverage 2.74x
Debt/Equity 13.75x
Stability
79 /100
Stable Profitable years 6
EPS volatility 24.76%
Beta 0.38x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NRC
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Trent Green
Employees
357
Headquarters
Lincoln
Upcoming events
25 SEP
Ex-Dividend
Ex-dividend date
09 OCT
Dividend Payment
Payment date
26 OCT
Earnings
Upcoming earnings report